Literature DB >> 24566181

Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii.

Esther Zander1, Rémy A Bonnin, Harald Seifert, Paul G Higgins.   

Abstract

The acquired carbapenem-hydrolyzing oxacillinase (OXA) OXA-143 has thus far been detected only in Acinetobacter baumannii isolates from Brazil. The aim of this study was to characterize three OXA-143 variants: OXA-231 and OXA-253 from carbapenem-resistant A. baumannii isolates and OXA-255 in a carbapenem-susceptible Acinetobacter pittii isolate originating from Brazil, Honduras, and the United States, respectively. The 5' rapid amplification of cDNA ends (RACE) technique identified the same transcription initiation site for all blaOXA-143-like genes and revealed differences in the putative promoter regions. However, all cloned OXA-143 variants conferred carbapenem resistance on A. baumannii ATCC 17978 and OXA-255 conferred carbapenem resistance on A. pittii SH024, which was correlated with blaOXA-255 gene expression. This is the first description of OXA-143-like outside A. baumannii. Detection of OXA-143-like in the United States and Honduras indicates its dissemination through the American continent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566181      PMCID: PMC3993222          DOI: 10.1128/AAC.02618-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

Review 1.  TonB-dependent receptors-structural perspectives.

Authors:  Andrew D Ferguson; Johann Deisenhofer
Journal:  Biochim Biophys Acta       Date:  2002-10-11

2.  First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic.

Authors:  T W Boo; F Walsh; B Crowley
Journal:  J Antimicrob Chemother       Date:  2006-08-17       Impact factor: 5.790

3.  Emergence of OXA-72-producing Acinetobacter pittii clinical isolates.

Authors:  Rémy A Bonnin; Fernando Docobo-Pérez; Laurent Poirel; Maria-Virginia Villegas; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2013-11-05       Impact factor: 5.283

4.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

6.  A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation.

Authors:  Kyoung-Hee Choi; Ayush Kumar; Herbert P Schweizer
Journal:  J Microbiol Methods       Date:  2005-06-28       Impact factor: 2.363

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 8.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

9.  Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.

Authors:  Hui Wang; Ping Guo; Hongli Sun; He Wang; Qiwen Yang; Minjun Chen; Yingchun Xu; Yuanjue Zhu
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

10.  OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii.

Authors:  B A Evans; A Hamouda; K J Towner; S G B Amyes
Journal:  Clin Microbiol Infect       Date:  2008-01-10       Impact factor: 8.067

View more
  10 in total

1.  First Report of the Carbapenemase Gene blaOXA-499 in Acinetobacter pittii.

Authors:  Roshan D'Souza; Naina Adren Pinto; Paul G Higgins; Insik Hwang; Dongeun Yong; Jongrak Choi; Kyoungwon Lee; Yunsop Chong
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Concentration and Variety of Carbapenemase Producers in Recreational Coastal Waters Showing Distinct Levels of Pollution.

Authors:  Raphael P Paschoal; Eloiza H Campana; Laís L Corrêa; Lara F Montezzi; Lina R L Barrueto; Isadora R da Silva; Raquel R Bonelli; Laura de S Castro; Renata C Picão
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

3.  Acinetobacter pittii from Companion Animals Coharboring blaOXA-58, the tet(39) Region, and Other Resistance Genes on a Single Plasmid.

Authors:  Peter Klotz; Lisa Jacobmeyer; Ursula Leidner; Ivonne Stamm; Torsten Semmler; Christa Ewers
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Evaluation of a loop-mediated isothermal amplification-based methodology to detect carbapenemase carriage in Acinetobacter clinical isolates.

Authors:  Andrea Vergara; Yuliya Zboromyrska; Noraida Mosqueda; María Isabel Morosini; Sergio García-Fernández; Ignasi Roca; Rafael Cantón; Francesc Marco; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

5.  A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A.

Authors:  Dieter Mitteregger; Julian Wessely; Ivan Barišić; Branka Bedenić; Dieter Kosak; Michael Kundi
Journal:  Pathogens       Date:  2022-04-18

6.  Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance.

Authors:  Prabhu Raj Joshi; Mahesh Acharya; Trishna Kakshapati; Udomluk Leungtongkam; Rapee Thummeepak; Sutthirat Sitthisak
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-07       Impact factor: 4.887

7.  Whole-Genome Sequence of a Colombian Acinetobacter baumannii Strain, a Coproducer of OXA-72 and OXA-255-Like Carbapenemases.

Authors:  Sandra Yamile Saavedra; Diego Prada-Cardozo; Verónica Rincón; Hermes Pérez-Cardona; Andrea Melissa Hidalgo; María Nilse González; María T Reguero; Emilia M Valenzuela de Silva; José R Mantilla; Laurent Falquet; Emiliano Barreto-Hernández; Carolina Duarte
Journal:  Genome Announc       Date:  2017-02-16

8.  Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru.

Authors:  Saúl Levy-Blitchtein; Ignasi Roca; Stefany Plasencia-Rebata; William Vicente-Taboada; Jorge Velásquez-Pomar; Laura Muñoz; Javier Moreno-Morales; Maria J Pons; Juana Del Valle-Mendoza; Jordi Vila
Journal:  Emerg Microbes Infect       Date:  2018-07-04       Impact factor: 7.163

Review 9.  Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.

Authors:  Maria Soledad Ramirez; Robert A Bonomo; Marcelo E Tolmasky
Journal:  Biomolecules       Date:  2020-05-06

10.  Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant Acinetobacter baumannii from Austria.

Authors:  Andrea J Grisold; Josefa Luxner; Branka Bedenić; Magda Diab-Elschahawi; Michael Berktold; Agnes Wechsler-Fördös; Gernot E Zarfel
Journal:  Int J Environ Res Public Health       Date:  2021-02-23       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.